• 
  Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, et al.. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast, Elsevier, 2020, 52, pp.50-57. ⟨10.1016/j.breast.2020.04.009⟩. ⟨hal-02888009⟩
• 
  Cécile Charles, Aurélie Bardet, Alicia Larive, Philip Gorwood, Nicolas Ramoz, et al.. Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France. JAMA Network Open, American Medical Association, 2022, 5 (4), pp.e225118. ⟨10.1001/jamanetworkopen.2022.5118⟩. ⟨inserm-03650391⟩
• 
  Fabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, Matthieu Carton, William Jacot, et al.. Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. Breast, Elsevier, 2022, 63, pp.54-60. ⟨10.1016/j.breast.2022.03.004⟩. ⟨hal-03647242⟩
• 
  B Teste, P Rouanet, J-J Tuech, A Valverde, B Lelong, et al.. Early and late morbidity of local excision after chemoradiotherapy for rectal cancer. BJS Open, Oxford University Press, 2021, 5 (3), pp.zrab043. ⟨10.1093/bjsopen/zrab043⟩. ⟨hal-03637680⟩
• 
  Nadia Oubaya, Pierre Soubeyran, Nicoleta Reinald, Marianne Fonck, Mylene Allain, et al.. Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts. Cancers, MDPI, 2021, 13 (24), pp.6154. ⟨10.3390/cancers13246154⟩. ⟨hal-03540655⟩
• 
  David Pasquier, Amélie Darlix, Guillaume Louvel, Julien Fraisse, William Jacot, et al.. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. European Journal of Cancer, Elsevier, 2020, 125, pp.22-30. ⟨10.1016/j.ejca.2019.11.001⟩. ⟨hal-02887998⟩
• 
  Carole Pflumio, Idriss Troussier, Xu Shan Sun, Julia Salleron, Claire Petit, et al.. Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study. European Journal of Cancer, Elsevier, 2019, 111, pp.69 - 81. ⟨10.1016/j.ejca.2019.01.004⟩. ⟨hal-03486172⟩
• 
  Mylene Annonay, Lisa Gauquelin, Romain Geiss, Mony Ung, Laurence Cristol-Dalstein, et al.. Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database. Breast, Elsevier, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩. ⟨hal-03468488⟩
• 
  Benjamin Cuer, Thierry Conroy, Beata Juzyna, Sophie Gourgou, Caroline Mollevi, et al.. Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials. Quality of Life Research, Springer Verlag, In press, ⟨10.1007/s11136-021-03040-8⟩. ⟨hal-03467977⟩
• 
  Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy de Troyer, Pierre Gimbergues, et al.. Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial. npj Breast Cancer, Nature, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩. ⟨hal-03406273⟩
• 
  Xavier Pivot, Gilles Romieu, Marc Debled, Jean-Yves Pierga, Pierre Kerbrat, et al.. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. The Lancet, Elsevier, 2019, 393 (10191), pp.2591-2598. ⟨inserm-02944688⟩
• 
  Antoine Adenis, J. Bennouna, P.L. Etienne, E. Bogart, E. Francois, et al.. Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS). European Journal of Cancer, Elsevier, 2019, 111, pp.12-20. ⟨10.1016/j.ejca.2019.01.016⟩. ⟨hal-02418932⟩
• 
  S. Carrere, R. Tetreau, C. Honore, D. Tzanis, J.-B. Delhorme, et al.. Quelle prise en charge optimale pour un sarcome du cordon spermatique en 2018 ?. Progrès en Urologie, Elsevier Masson, 2019, 29 (1), pp.12-17. ⟨10.1016/j.purol.2018.09.010⟩. ⟨hal-02462346⟩
• 
  Yungan Tao, Anne Auperin, Pierre Blanchard, Marc Alfonsi, Xu-Shan Sun, et al.. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial. Radiotherapy and Oncology, Elsevier, 2020, 150, pp.18-25. ⟨10.1016/j.radonc.2020.05.021⟩. ⟨hal-02882291⟩
• 
  Gwenaelle Gravis, Jean-Marie Boher, Karim Fizazi, Florence Joly, Franck Priou, et al.. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model. European Urology, Elsevier, 2015, 68 (2), pp.196 - 204. ⟨10.1016/j.eururo.2014.09.022⟩. ⟨inserm-03353959⟩
• 
  Amanda Bortolini Silveira, François-Clément Bidard, Marie-Laure Tanguy, Elodie Girard, Olivier Trédan, et al.. Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. npj Breast Cancer, Nature, 2021, 7, pp.115. ⟨10.1038/s41523-021-00319-4⟩. ⟨hal-03345255⟩
• 
  Christine Lonjou, Séverine Eon‐marchais, Thérèse Truong, Marie‐gabrielle Dondon, Mojgan Karimi, et al.. Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility. International Journal of Cancer, Wiley, 2021, 148 (8), pp.1895-1909. ⟨10.1002/ijc.33457⟩. ⟨hal-03345363⟩
• 
  Gwenaelle Gravis, Jean-Marie Boher, Florence Joly, Michel Soulié, Laurence Albiges, et al.. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial. European Urology, Elsevier, 2016, 70, pp.256 - 262. ⟨10.1016/j.eururo.2015.11.005⟩. ⟨inserm-03343628⟩
• 
  Simon Heeke, Jonathan Benzaquen, Audrey Vallee, Maryline Allegra, Julien Mazieres, et al.. Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay. Annals of translational medicine, AME Publishing Company, 2021, 9 (11), pp.922 - 922. ⟨10.21037/atm-20-7900⟩. ⟨hal-03343344⟩
• 
  M. Carausu, M. Carton, A. Darlix, D. Pasquier, M. Leheurteur, et al.. Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database. ESMO Open, European Society for Medical Oncology, 2021, 6 (3), pp.100150. ⟨10.1016/j.esmoop.2021.100150⟩. ⟨hal-03287137⟩

183